| NCT05707429 |
Sexual Function and Quality of Life Among Patients Suffering From Inflammatory Bowel Disease(Inactive Stage) |
NULL |
COMPLETED |
Assiut University |
Sexual Function Disturbances|Inflammatory Bowel D… |
OTHER: The Arabic version of The International In… |
Details |
| NCT05701501 |
Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD |
NA |
UNKNOWN |
Changhai Hospital |
Inflammatory Bowel Diseases |
DRUG: Vitamin B5 Tablets|DRUG: placebo |
Details |
| NCT05688852 |
VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease |
PHASE2 |
TERMINATED |
Ventyx Biosciences, Inc |
Crohn Disease |
DRUG: VTX958|DRUG: VTX958|DRUG: VTX958 Placebo |
Details |
| NCT05687474 |
Baby Detect : Genomic Newborn Screening |
NULL |
COMPLETED |
Centre Hospitalier Universitaire de Liege |
Congenital Adrenal Hyperplasia|Familial Hyperinsu… |
None |
Details |
| NCT05684484 |
Role of Roflumilast in Ulcerative Colitis |
PHASE4 |
COMPLETED |
Tanta University |
Ulcerative Colitis |
DRUG: Roflumilast 500 MCG Oral Tablet [DALIRESP]|… |
Details |
| NCT05668013 |
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease |
PHASE2 |
ACTIVE_NOT_RECRUITING |
Teva Branded Pharmaceutical Products R&D LLC |
Crohn Disease|Colitis, Ulcerative |
DRUG: TEV-48574 Dose Regimen A|DRUG: TEV-48574 Do… |
Details |
| NCT05666960 |
R-3750 in Patients With Mild to Moderate Ulcerative Colitis |
PHASE1 |
RECRUITING |
Rise Therapeutics LLC |
Ulcerative Colitis Chronic Mild|Ulcerative Coliti… |
DRUG: R-3750 |
Details |
| NCT05663671 |
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD |
NULL |
UNKNOWN |
Meharry Medical College |
Inflammatory Bowel Diseases|Ulcerative Colitis|Cr… |
DIAGNOSTIC_TEST: Diagnostic Test |
Details |
| NCT05659953 |
LMT503 First-in-human SAD, MAD, and FE Study |
PHASE1 |
NOT_YET_RECRUITING |
Lmito Therapeutics Inc. |
Inflammatory Bowel Disease|Colitis, Ulcerative|Cr… |
DRUG: LMT503|DRUG: Placebo |
Details |
| NCT05643534 |
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years |
PHASE3 |
RECRUITING |
Ardelyx |
Irritable Bowel Syndrome With Constipation (IBS-C) |
DRUG: Tenapanor 50 MG|DRUG: Tenapanor 25 mg bid|D… |
Details |
| NCT05638347 |
A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. |
PHASE1 |
COMPLETED |
Atridia Pty Ltd. |
Inflammatory Bowel Disease |
DRUG: HRS-7085 tablets|DRUG: Placebo tablet |
Details |
| NCT05624801 |
Cholecalciferol Comedication in Patients With Chronic Inflammatory Bowel Diseases (Crohn's Disease or Ulcerative Colitis) - the 5C-study |
PHASE3 |
Recruiting |
University Hospital, Basel, Switzerland |
IBD |
Drug: D3 VitaCaps |
Details |
| NCT07168434 |
Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome |
PHASE3 |
RECRUITING |
Biocodex |
IBS (Irritable Bowel Syndrome)|IBS-D (Diarrhea-pr… |
DRUG: Saccharomyces Boulardii 250 MG|DRUG: Placeb… |
Details |
| NCT05611671 |
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC |
PHASE2 |
ACTIVE_NOT_RECRUITING |
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) |
Inflammatory Bowel Diseases|Colitis, Ulcerative |
DRUG: MORF-057|DRUG: Placebo |
Details |
| NCT05549323 |
A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis |
PHASE1 |
TERMINATED |
Pfizer |
Ulcerative Colitis |
DRUG: PF-07054894|DRUG: Placebo |
Details |
| NCT07161297 |
Remimazolam for Colonoscopy in IBD Patients |
PHASE4 |
NOT_YET_RECRUITING |
Humanitas Clinical and Research Center |
IBD (Inflammatory Bowel Disease) |
DRUG: Intravenous remimazolam (5 mg initially, wi… |
Details |
| NCT05499130 |
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease |
PHASE2 |
COMPLETED |
Teva Branded Pharmaceutical Products R&D, Inc. |
Crohn Disease|Colitis, Ulcerative |
DRUG: TEV-48574|DRUG: Placebo |
Details |
| NCT05486104 |
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis |
PHASE2 |
ACTIVE_NOT_RECRUITING |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Moderate to Severe Ulcerative Colitis |
DRUG: Hemay005 tablets|DRUG: Hemay005 placebo tab… |
Details |
| NCT07156929 |
Kinetics and Metabolism of Nicotinamide Provided as a Dietary Supplementation |
NA |
COMPLETED |
University Hospital Schleswig-Holstein |
Respiratory Infection (for Example, Pneumonia, Br… |
DIETARY_SUPPLEMENT: Controlled-ileocolonic-releas… |
Details |
| NCT05471492 |
Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease |
PHASE2 |
WITHDRAWN |
Telavant, Inc. |
Crohn Disease |
DRUG: Investigational Product|DRUG: Placebo |
Details |
